GAM Holding’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-8,398
Closed -$696K 231
2022
Q2
$696K Hold
8,398
0.05% 197
2022
Q1
$648K Sell
8,398
-2,164
-20% -$167K 0.03% 216
2021
Q4
$933K Hold
10,562
0.04% 201
2021
Q3
$816K Buy
10,562
+1
+0% +$77 0.04% 209
2021
Q2
$881K Sell
10,561
-12,241
-54% -$1.02M 0.04% 227
2021
Q1
$1.72M Buy
+22,802
New +$1.72M 0.08% 207
2020
Q4
Sell
-22,811
Closed -$1.74M 279
2020
Q3
$1.74M Sell
22,811
-6,689
-23% -$509K 0.1% 211
2020
Q2
$3.64M Sell
29,500
-9,713
-25% -$1.2M 0.23% 135
2020
Q1
$3.31M Sell
39,213
-3,194
-8% -$270K 0.23% 123
2019
Q4
$3.59M Buy
42,407
+7
+0% +$592 0.17% 156
2019
Q3
$2.86M Hold
42,400
0.13% 186
2019
Q2
$3.63M Hold
42,400
0.14% 162
2019
Q1
$3.77M Sell
42,400
-1,202
-3% -$107K 0.16% 154
2018
Q4
$3.71M Sell
43,602
-5,100
-10% -$434K 0.19% 134
2018
Q3
$4.72M Buy
48,702
+27,452
+129% +$2.66M 0.17% 146
2018
Q2
$2M Buy
21,250
+19,300
+990% +$1.82M 0.07% 287
2018
Q1
$158K Buy
+1,950
New +$158K 0.01% 800
2017
Q3
Sell
-10,495
Closed -$953K 585
2017
Q2
$953K Hold
10,495
0.01% 652
2017
Q1
$921K Sell
10,495
-7,456
-42% -$654K 0.01% 666
2016
Q4
$1.49M Buy
17,951
+8,411
+88% +$697K 0.03% 546
2016
Q3
$883K Buy
9,540
+4,650
+95% +$430K 0.02% 631
2016
Q2
$380K Sell
4,890
-28,265
-85% -$2.2M 0.01% 790
2016
Q1
$2.74M Sell
33,155
-56,174
-63% -$4.63M 0.05% 391
2015
Q4
$9.36M Buy
89,329
+33,651
+60% +$3.53M 0.15% 174
2015
Q3
$5.86M Buy
55,678
+32,814
+144% +$3.46M 0.1% 223
2015
Q2
$3.13M Sell
22,864
-1,736
-7% -$237K 0.05% 399
2015
Q1
$3.07M Sell
24,600
-68,600
-74% -$8.55M 0.05% 401
2014
Q4
$8.43M Sell
93,200
-20,860
-18% -$1.89M 0.13% 198
2014
Q3
$8.23M Buy
114,060
+24,000
+27% +$1.73M 0.12% 209
2014
Q2
$5.6M Buy
90,060
+14,982
+20% +$932K 0.09% 259
2014
Q1
$5.12M Hold
75,078
0.08% 276
2013
Q4
$5.28M Buy
75,078
+1,142
+2% +$80.3K 0.09% 248
2013
Q3
$5.34M Sell
73,936
-4,600
-6% -$332K 0.1% 238
2013
Q2
$4.38M Buy
+78,536
New +$4.38M 0.1% 259